Clinical Trials in Michigan

Showing 4081-4100 of 16,154 trials

Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems

NCT06391073

Emergency department visits provide an opportunity to identify people with undiagnosed, untreated, or uncontrolled high blood pressure. In Reach Out, we will test whether a mobile health intervention yields a greater reduction in blood pressure than usual care among individuals identified with high blood pressure during a safety-net emergency department visit. Subsequently, we will estimate the reduction in heart attack, stroke, and dementia if Reach Out were implemented across all U.S. safety-net emergency departments.

Hypertension

Northwestern University500 participantsStarted Jul 2024

Flint, Michigan, United States

Active Not RecruitingPhase 162 miles

QTX3046 in Patients With KRAS G12D Mutations

NCT06428500

Phase 1 study to determine the safety and tolerability of QTX3046 as a single agent or in combination with cetuximab.

Advanced Solid Tumor

Quanta Therapeutics240 participantsStarted May 2024

Grand Rapids, Michigan, United States • Durham, North Carolina, United States • Houston, Texas, United States +2 more locations

RECRUITING83 miles

International CIPN Assessment and Validation Study

NCT04633655

This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an international multi-center study.

Chemotherapy-induced Peripheral NeuropathyQuality of Life

University of Milano Bicocca1,000 participantsStarted Jun 2020

Birmingham, Alabama, United States • Atlanta, Georgia, United States • Baltimore, Maryland, United States +27 more locations

Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems

QTX3046 in Patients With KRAS G12D Mutations

International CIPN Assessment and Validation Study

Find Trials by Condition in Michigan

This Study Will Collect Clinical and Patient Reported Experience Data From Participants Requiring Urine Output Management Overnight in the Home Setting.

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study)

Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia

Virtual Care to Improve Heart Failure Outcomes (VITAL-HF)

Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

Secur-Fit Advanced Outcomes Study

Rhythm Express Wearable System vs. Simultaneous Polysomnography for the Diagnosis of Obstructive Sleep Apnea in Adults With Suspected or Observed Atrial Fibrillation

A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma

Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency

Open-Label Surufatinib in European Patients With NET